True Health Declines to Assume BG Medicine Galectin-3 Supply Agreement | GenomeWeb

NEW YORK (GenomeWeb) – BG Medicine said in its most recent 10K filing that laboratory firm True Health Diagnostics (THD) has declined to assume a supply agreement for BG's galectin-3 tests.

The agreement was originally established between BG and Health Diagnostics Laboratory (HDL), which filed for bankruptcy in June 2015. THD last year acquired the assets of HDL, which was formerly BG's largest customer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.